On May 6, 2025, Leidos Holdings Inc (LDOS, Financial) released its 8-K filing for the first quarter of fiscal year 2025, showcasing impressive financial performance. The company, a leader in technology, engineering, and science solutions for defense, intelligence, civil, and health markets, reported revenues of $4.25 billion, marking a 7% increase year-over-year. This figure slightly exceeded the analyst estimate of $4.247 billion. Net income for the quarter was $365 million, translating to $2.77 per diluted share, surpassing the estimated earnings per share (EPS) of $2.47.
Leidos Holdings Inc (LDOS, Financial) demonstrated significant growth in its financial metrics, with a notable 30% year-over-year increase in non-GAAP diluted EPS to $2.97. The company's adjusted EBITDA reached $601 million, reflecting a 23% increase from the previous year, with an adjusted EBITDA margin of 14.2%, up from 12.3%. These achievements underscore Leidos' effective execution of its NorthStar 2030 Strategy, which focuses on enhancing customer outcomes through innovative technologies.
Our robust first quarter results build on the momentum from 2024, demonstrating the team's ability to execute in a dynamic environment that demands agility and innovation," stated Leidos Chief Executive Officer Tom Bell.
Leidos Holdings Inc (LDOS, Financial) reported a net income margin of 8.6%, an improvement from 7.1% in the first quarter of 2024. The company's cash flows from operations were $58 million, with a free cash flow of $36 million. The strong EBITDA and collections performance were key drivers of the operating cash flow. Additionally, Leidos issued $1 billion in senior unsecured notes to refinance existing debt and fund a $500 million accelerated share repurchase, reflecting confidence in its strategic positioning.
The company's four reportable segments—National Security & Digital, Health & Civil, Commercial & International, and Defense Systems—each contributed to the revenue growth. Notably, the Health & Civil segment saw an 8% increase in revenues, driven by higher volumes and case complexity in managed health services. Leidos also secured several significant contracts, including a $205 million task order with the Defense Threat Reduction Agency and a $148 million contract with the U.S. Air Force for Project Night Owl.
Leidos Holdings Inc (LDOS, Financial) continues to demonstrate resilience and adaptability in a competitive industry. The company's strategic investments in technology and its focus on customer-centric solutions are pivotal to its sustained growth. The reaffirmation of its full-year guidance, with expected revenues between $16.90 billion and $17.30 billion, further emphasizes its strong market position. As Leidos advances its strategic initiatives, it remains well-positioned to capitalize on emerging opportunities in the defense and technology sectors.
Explore the complete 8-K earnings release (here) from Leidos Holdings Inc for further details.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.